First Command Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.9K Hold
167
﹤0.01% 352
2025
Q4
$58.5K Buy
167
+5
+3% +$1.69K ﹤0.01% 300
2025
Q3
$52.3K Sell
162
-61
-27% -$19K ﹤0.01% 300
2025
Q2
$86.7K Buy
223
+43
+24% +$17.3K ﹤0.01% 243
2025
Q1
$78.3K Hold
180
﹤0.01% 242
2024
Q4
$66.4K Sell
180
-4
-2% -$1.67K ﹤0.01% 253
2024
Q3
$95.7K Buy
184
+4
+2% +$2.14K ﹤0.01% 234
2024
Q2
$97.5K Hold
180
﹤0.01% 211
2024
Q1
$93.3K Hold
180
﹤0.01% 212
2023
Q4
$84.9K Hold
180
﹤0.01% 204
2023
Q3
$78.4K Buy
+180
New +$81.6K ﹤0.01% 209

Other funds holding ELV

First Command Advisory Services's ELV Position: Q1 2026 in Review

First Command Advisory Services held its Elevance Health (ELV) position steady in Q1 2026 at 167 shares worth $48.9K. The position accounts for ﹤0.01% of the portfolio, ranked #352.

First Command Advisory Services first reported a position in ELV in Q3 2023 and has held it in 11 quarters since. The position peaked at $97.5K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • First Command Advisory Services held 167 shares of Elevance Health worth $48.9K as of Q1 2026.
  • First Command Advisory Services left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up ﹤0.01% of First Command Advisory Services's portfolio in Q1 2026, its #352 holding.
  • First Command Advisory Services first reported a position in Elevance Health in Q3 2023 and has held it in 11 quarters since.
  • First Command Advisory Services's Elevance Health position peaked at $97.5K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on First Command Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.